A detailed history of Baldwin Brothers LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 21,290 shares of CRL stock, worth $3.96 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
21,290
Previous 22,260 4.36%
Holding current value
$3.96 Million
Previous $4.6 Million 8.81%
% of portfolio
0.29%
Previous 0.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$187.96 - $245.29 $182,321 - $237,931
-970 Reduced 4.36%
21,290 $4.19 Million
Q2 2024

Jul 12, 2024

SELL
$206.39 - $268.73 $24,147 - $31,441
-117 Reduced 0.52%
22,260 $4.6 Million
Q1 2024

Apr 12, 2024

BUY
$203.52 - $273.43 $4.53 Million - $6.09 Million
22,266 Added 20059.46%
22,377 $6.06 Million
Q4 2023

Jan 08, 2024

SELL
$164.52 - $238.84 $3,619 - $5,254
-22 Reduced 16.54%
111 $26,000
Q3 2021

Oct 27, 2021

BUY
$372.64 - $458.3 $49,561 - $60,953
133 New
133 $55,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.